Possible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequences
- 19 May 2010
- journal article
- Published by Elsevier BV in Neuroscience
- Vol. 167 (3), 880-893
- https://doi.org/10.1016/j.neuroscience.2010.02.011
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Evidence that opioids may have toll-like receptor 4 and MD-2 effectsBrain, Behavior, and Immunity, 2010
- The “Toll” of Opioid-Induced Glial Activation: Improving the Clinical Efficacy of Opioids by Targeting GliaTrends in Pharmacological Sciences, 2009
- Minocycline suppresses morphine-induced respiratory depression, suppresses morphine-induced reward, and enhances systemic morphine-induced analgesiaBrain, Behavior, and Immunity, 2008
- Proinflammatory cytokines oppose opioid-induced acute and chronic analgesiaBrain, Behavior, and Immunity, 2008
- Non‐stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll‐like receptor 4 (TLR4)European Journal of Neuroscience, 2008
- p38 Mitogen-activated protein kinase inhibitor SB203580 reverses the antianalgesia induced by dextro-morphine or morphine in the mouse spinal cordEuropean Journal of Pharmacology, 2006
- Antianalgesia: Stereoselective Action ofdextro-Morphine overlevo-Morphine on Glia in the Mouse Spinal CordThe Journal of pharmacology and experimental therapeutics, 2005
- Morphine Enhances Complement Receptor-Mediated Phagocytosis ofCryptococcus neoformansby Human MicrogliaClinical Immunology and Immunopathology, 1998
- The opioid–cytokine connectionJournal of Neuroimmunology, 1998
- The moderator–mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations.Journal of Personality and Social Psychology, 1986